ASEX
ILYDA
Market cap50mUSD
Nov 12, Last price
5.26EUR
Name
Ilyda SA
Chart & Performance
P/E
11.33
P/S
6.08
EPS
0.46
Div Yield, %
0.38%
Shrs. gr., 5y
10.53%
Rev. gr., 5y
20.42%
Revenues
7m
+73.29%
Net income
4m
+232.95%
CFO
3m
+17.82%
Dividend
Jul 18, 20240.02 EUR/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Ilyda SA engages in software development business in Greece. It offers enterprise resource planning systems, such as MegaTron ERP and Kinitron Smart ERP; Dioscourides Smart, Dioscourides XPress, and Dioscourides ERP Retail System for pharmacies; MegaTron Pharma ERP for drugstores; and LIS Bio-Diagnosis for microbiological laboratories. The company also provides MegaTron DEVA for water supply/sewerage companies; PSIS Financial Management for public sector companies; PSIS Payroll & Personnel Management for legal entities; and SIS Secretariats of Educational Institutions for educational institutions. In addition, it provides software support services, such as telephone support, remote support, on-site support, and feedback support services; project design and implementation; and software training services. The company was founded in 1992 and is headquartered in Athens, Greece.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||